Clinical Trial Update: Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating biomarker strategies for medication-enhanced cognitive training in schizophrenia has completed enrollment with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of California, San Diego | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-10